Impressive potential with 30 to 40 mio new patients globally every year. No drugs currently available. Novel approach from NYR in this study. lf successful for humans, this drug can improve quality of life for an enormous amount of people and set NYR up for a market cap in the billions.
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury, page-61
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
